Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MRNA |
---|---|---|
09:32 ET | 459536 | 135.605 |
09:34 ET | 19380 | 133.33 |
09:36 ET | 41170 | 132.425 |
09:38 ET | 10679 | 133.4 |
09:39 ET | 4608 | 133.45 |
09:41 ET | 7279 | 133.73 |
09:43 ET | 21525 | 133.97 |
09:45 ET | 22438 | 133.1 |
09:48 ET | 10771 | 134.56 |
09:50 ET | 24295 | 135.395 |
09:52 ET | 13338 | 135.1538 |
09:54 ET | 5014 | 134.1907 |
09:56 ET | 5565 | 134.9 |
09:57 ET | 2644 | 134.22 |
09:59 ET | 4783 | 134.595 |
10:01 ET | 4522 | 134.94 |
10:03 ET | 10435 | 135.205 |
10:06 ET | 4537 | 135.2 |
10:08 ET | 10870 | 135.68 |
10:10 ET | 6264 | 135.32 |
10:12 ET | 7339 | 135.3 |
10:14 ET | 1386 | 135.375 |
10:15 ET | 2982 | 135.65 |
10:17 ET | 6249 | 135.63 |
10:19 ET | 6099 | 135.58 |
10:21 ET | 12997 | 135.24 |
10:24 ET | 23569 | 136.1 |
10:26 ET | 20629 | 135.99 |
10:28 ET | 3689 | 135.99 |
10:30 ET | 10549 | 135.93 |
10:32 ET | 4550 | 135.8 |
10:33 ET | 11265 | 136.015 |
10:35 ET | 44800 | 135.83 |
10:37 ET | 3005 | 135.72 |
10:39 ET | 21764 | 135.27 |
10:42 ET | 26667 | 134.92 |
10:44 ET | 3302 | 134.98 |
10:46 ET | 3590 | 135.43 |
10:48 ET | 21310 | 135.065 |
10:50 ET | 14246 | 135.34 |
10:51 ET | 10363 | 135.38 |
10:53 ET | 6899 | 135.73 |
10:55 ET | 10746 | 135.41 |
10:57 ET | 4794 | 135.325 |
11:00 ET | 6689 | 134.925 |
11:02 ET | 7899 | 134.99 |
11:04 ET | 2306 | 135.09 |
11:06 ET | 7377 | 135.025 |
11:08 ET | 5942 | 135.06 |
11:09 ET | 3051 | 134.74 |
11:11 ET | 3810 | 134.67 |
11:13 ET | 6785 | 135.0039 |
11:15 ET | 11557 | 134.81 |
11:18 ET | 4905 | 135 |
11:20 ET | 6309 | 134.975 |
11:22 ET | 4429 | 135.05 |
11:24 ET | 3001 | 135 |
11:26 ET | 5783 | 135.02 |
11:27 ET | 7225 | 134.46 |
11:29 ET | 17546 | 134.5 |
11:31 ET | 3177 | 134.74 |
11:33 ET | 7454 | 134.87 |
11:36 ET | 8338 | 135.145 |
11:38 ET | 14997 | 134.91 |
11:40 ET | 7719 | 134.75 |
11:42 ET | 2422 | 134.84 |
11:44 ET | 2000 | 134.94 |
11:45 ET | 7209 | 134.84 |
11:47 ET | 39185 | 135.01 |
11:49 ET | 8117 | 134.845 |
11:51 ET | 2707 | 134.99 |
11:54 ET | 12079 | 135.37 |
11:56 ET | 9577 | 134.965 |
11:58 ET | 2468 | 135.07 |
12:00 ET | 1304 | 135.125 |
12:02 ET | 5327 | 135.41 |
12:03 ET | 13972 | 135.19 |
12:05 ET | 1700 | 135.325 |
12:07 ET | 6261 | 135.25 |
12:09 ET | 6412 | 135.11 |
12:12 ET | 3104 | 135.22 |
12:14 ET | 3335 | 135.37 |
12:16 ET | 2187 | 135.2 |
12:18 ET | 3028 | 135.24 |
12:20 ET | 11208 | 134.985 |
12:21 ET | 5197 | 134.51 |
12:23 ET | 2447 | 134.27 |
12:25 ET | 1390 | 134.46 |
12:27 ET | 5595 | 134.225 |
12:30 ET | 3980 | 134.62 |
12:32 ET | 5600 | 134.99 |
12:34 ET | 3944 | 134.93 |
12:36 ET | 1683 | 134.86 |
12:38 ET | 2434 | 134.895 |
12:39 ET | 1872 | 134.63 |
12:41 ET | 1352 | 134.54 |
12:43 ET | 1739 | 134.585 |
12:45 ET | 1913 | 134.43 |
12:48 ET | 2782 | 134.2 |
12:50 ET | 2426 | 134.22 |
12:52 ET | 2646 | 134.19 |
12:54 ET | 4864 | 134.33 |
12:56 ET | 2540 | 134.435 |
12:57 ET | 2200 | 134.565 |
12:59 ET | 3252 | 134.44 |
01:01 ET | 1400 | 134.565 |
01:03 ET | 3000 | 134.385 |
01:06 ET | 607 | 134.435 |
01:08 ET | 703 | 134.39 |
01:10 ET | 1590 | 134.2685 |
01:12 ET | 700 | 134.35 |
01:14 ET | 500 | 134.35 |
01:15 ET | 3863 | 134.155 |
01:17 ET | 1504 | 134.13 |
01:19 ET | 7812 | 133.94 |
01:21 ET | 400 | 133.885 |
01:24 ET | 1153 | 133.765 |
01:26 ET | 2800 | 133.7 |
01:28 ET | 905 | 133.7949 |
01:30 ET | 2659 | 133.77 |
01:32 ET | 500 | 133.79 |
01:33 ET | 800 | 133.88 |
01:35 ET | 600 | 133.8 |
01:37 ET | 1966 | 133.77 |
01:39 ET | 100 | 133.92 |
01:42 ET | 500 | 133.82 |
01:44 ET | 2523 | 133.54 |
01:46 ET | 6130 | 133.45 |
01:48 ET | 2500 | 133.47 |
01:50 ET | 4190 | 133.84 |
01:51 ET | 800 | 133.915 |
01:53 ET | 3800 | 134.075 |
01:55 ET | 523 | 134.2586 |
01:57 ET | 2396 | 134.14 |
02:00 ET | 1100 | 133.87 |
02:02 ET | 2860 | 133.985 |
02:04 ET | 700 | 134.115 |
02:06 ET | 1000 | 134.29 |
02:08 ET | 4252 | 134.23 |
02:09 ET | 2750 | 134.4 |
02:11 ET | 400 | 134.44 |
02:13 ET | 3588 | 134.512 |
02:15 ET | 1503 | 134.485 |
02:18 ET | 3383 | 134.65 |
02:20 ET | 1637 | 134.49 |
02:22 ET | 311 | 134.655 |
02:24 ET | 2841 | 134.37 |
02:26 ET | 230 | 134.5 |
02:27 ET | 300 | 134.575 |
02:29 ET | 200 | 134.45 |
02:31 ET | 1300 | 134.41 |
02:33 ET | 900 | 134.205 |
02:36 ET | 1367 | 134.255 |
02:38 ET | 1410 | 134.1029 |
02:40 ET | 838 | 134.25 |
02:42 ET | 2595 | 134.16 |
02:44 ET | 300 | 134.165 |
02:45 ET | 498 | 134.19 |
02:47 ET | 1018 | 134.08 |
02:49 ET | 100 | 134.12 |
02:51 ET | 982 | 134.02 |
02:54 ET | 815 | 134.0796 |
02:56 ET | 1200 | 134.05 |
02:58 ET | 715 | 134.04 |
03:00 ET | 1259 | 134.0103 |
03:02 ET | 3991 | 133.91 |
03:03 ET | 2152 | 133.8225 |
03:05 ET | 2100 | 133.89 |
03:07 ET | 2619 | 133.58 |
03:09 ET | 1687 | 133.59 |
03:12 ET | 4770 | 133.83 |
03:14 ET | 4179 | 133.78 |
03:16 ET | 2813 | 133.89 |
03:18 ET | 4440 | 133.875 |
03:20 ET | 2433 | 133.64 |
03:21 ET | 5430 | 133.63 |
03:23 ET | 21180 | 134.17 |
03:25 ET | 5135 | 134 |
03:27 ET | 2326 | 134 |
03:30 ET | 24233 | 133.87 |
03:32 ET | 8046 | 134.06 |
03:34 ET | 8350 | 134.215 |
03:36 ET | 7460 | 134.125 |
03:38 ET | 3072 | 133.95 |
03:39 ET | 5746 | 134.27 |
03:41 ET | 14365 | 133.99 |
03:43 ET | 8818 | 133.9 |
03:45 ET | 13159 | 133.95 |
03:48 ET | 9479 | 133.705 |
03:50 ET | 8446 | 133.59 |
03:52 ET | 15673 | 134.15 |
03:54 ET | 26836 | 133.8 |
03:56 ET | 54216 | 133.255 |
03:57 ET | 39825 | 133.35 |
03:59 ET | 43589 | 133.4 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Moderna Inc | 51.5B | -8.5x | --- |
ICON PLC | 26.1B | 38.7x | +4.68% |
Biogen Inc | 32.8B | 28.0x | -18.14% |
Biontech SE | 20.4B | 166.3x | --- |
Grifols SA | 5.9B | 23.3x | --- |
Incyte Corp | 14.0B | 19.2x | +39.11% |
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. Its diverse development pipeline consists of 45 therapeutic and vaccine programs, nine of which are in late-stage development. Its products include COVID-19 vaccines (mRNA-1273/Spikevax, next-generation mRNA-1283), RSV vaccine (mRNA-1345), Seasonal influenza vaccines (mRNA-1010, mRNA-1011, mRNA-1012, mRNA-1020 and mRNA-1030), Combination vaccines (mRNA-1083, mRNA-1230, mRNA-1045 and mRNA-1365), CMV vaccine (mRNA-1647), EBV vaccine (mRNA-1189 and mRNA-1195) and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $51.5B |
---|---|
Revenue (TTM) | $5.2B |
Shares Outstanding | 383.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.67 |
EPS | $-15.66 |
Book Value | $36.27 |
P/E Ratio | -8.5x |
Price/Sales (TTM) | 10.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -99.73% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.